Structure

Physi-Chem Properties

Molecular Weight:  608.17
Volume:  572.663
LogP:  0.136
LogD:  -0.146
LogS:  -2.735
# Rotatable Bonds:  14
TPSA:  238.97
# H-Bond Aceptor:  15
# H-Bond Donor:  7
# Rings:  3
# Heavy Atoms:  15

MedChem Properties

QED Drug-Likeness Score:  0.11
Synthetic Accessibility Score:  4.493
Fsp3:  0.393
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -6.218
MDCK Permeability:  6.0733284044545144e-05
Pgp-inhibitor:  0.0
Pgp-substrate:  0.965
Human Intestinal Absorption (HIA):  0.845
20% Bioavailability (F20%):  0.755
30% Bioavailability (F30%):  0.997

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.13
Plasma Protein Binding (PPB):  64.78661346435547%
Volume Distribution (VD):  0.296
Pgp-substrate:  19.498456954956055%

ADMET: Metabolism

CYP1A2-inhibitor:  0.064
CYP1A2-substrate:  0.063
CYP2C19-inhibitor:  0.021
CYP2C19-substrate:  0.06
CYP2C9-inhibitor:  0.005
CYP2C9-substrate:  0.728
CYP2D6-inhibitor:  0.016
CYP2D6-substrate:  0.15
CYP3A4-inhibitor:  0.086
CYP3A4-substrate:  0.029

ADMET: Excretion

Clearance (CL):  1.963
Half-life (T1/2):  0.928

ADMET: Toxicity

hERG Blockers:  0.034
Human Hepatotoxicity (H-HT):  0.134
Drug-inuced Liver Injury (DILI):  0.85
AMES Toxicity:  0.052
Rat Oral Acute Toxicity:  0.019
Maximum Recommended Daily Dose:  0.003
Skin Sensitization:  0.086
Carcinogencity:  0.018
Eye Corrosion:  0.003
Eye Irritation:  0.009
Respiratory Toxicity:  0.012

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC469654

Natural Product ID:  NPC469654
Common Name*:   Shomaside D
IUPAC Name:   3-hydroxy-2-[(4-hydroxyphenyl)methyl]-4-methoxy-2-[(E)-3-[3-methoxy-4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]prop-2-enoyl]oxy-4-oxobutanoic acid
Synonyms:   Shomaside D
Standard InCHIKey:  SWZFUPSKOHNPFU-JUHWEFMQSA-N
Standard InCHI:  InChI=1S/C28H32O15/c1-39-18-11-14(5-9-17(18)41-26-23(34)22(33)21(32)19(13-29)42-26)6-10-20(31)43-28(27(37)38,24(35)25(36)40-2)12-15-3-7-16(30)8-4-15/h3-11,19,21-24,26,29-30,32-35H,12-13H2,1-2H3,(H,37,38)/b10-6+/t19-,21-,22+,23-,24?,26-,28?/m1/s1
SMILES:  OC[C@H]1O[C@@H](Oc2ccc(cc2OC)/C=C/C(=O)OC(C(C(=O)OC)O)(C(=O)O)Cc2ccc(cc2)O)[C@@H]([C@H]([C@@H]1O)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL1096592
PubChem CID:   46209908
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0004603] Organic oxygen compounds
      • [CHEMONTID:0000323] Organooxygen compounds
        • [CHEMONTID:0000011] Carbohydrates and carbohydrate conjugates
          • [CHEMONTID:0002105] Glycosyl compounds
            • [CHEMONTID:0004165] Phenolic glycosides

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO32999 cimicifuga heracleifolia Species Ranunculaceae Eukaryota n.a. n.a. n.a. PMID[20192237]
NPO30530 Cimicifuga dahurica Species Ranunculaceae Eukaryota n.a. n.a. n.a. PMID[20192237]
NPO30530 Cimicifuga dahurica Species Ranunculaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO30530 Cimicifuga dahurica Species Ranunculaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT2 Others Unspecified IC50 > 658000.0 nM PMID[557197]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC469654 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9933 High Similarity NPC40920
0.9933 High Similarity NPC223335
0.9803 High Similarity NPC44507
0.9226 High Similarity NPC163635
0.9161 High Similarity NPC38699
0.9145 High Similarity NPC478242
0.9139 High Similarity NPC283081
0.9139 High Similarity NPC221383
0.9139 High Similarity NPC299090
0.9139 High Similarity NPC143892
0.9067 High Similarity NPC304956
0.9038 High Similarity NPC131532
0.9038 High Similarity NPC10205
0.9032 High Similarity NPC44730
0.9032 High Similarity NPC115466
0.9032 High Similarity NPC245615
0.9032 High Similarity NPC61604
0.9032 High Similarity NPC299706
0.9026 High Similarity NPC300329
0.902 High Similarity NPC111785
0.9007 High Similarity NPC53884
0.9007 High Similarity NPC258671
0.8981 High Similarity NPC478055
0.8981 High Similarity NPC471405
0.8974 High Similarity NPC191046
0.8974 High Similarity NPC327032
0.8974 High Similarity NPC194095
0.8968 High Similarity NPC36130
0.8968 High Similarity NPC134905
0.8968 High Similarity NPC95498
0.8968 High Similarity NPC246566
0.8961 High Similarity NPC259576
0.8961 High Similarity NPC158635
0.8961 High Similarity NPC221091
0.8961 High Similarity NPC229882
0.8951 High Similarity NPC128403
0.8924 High Similarity NPC226759
0.891 High Similarity NPC137813
0.8882 High Similarity NPC227297
0.8874 High Similarity NPC478239
0.8854 High Similarity NPC477299
0.8854 High Similarity NPC160882
0.8831 High Similarity NPC116229
0.8812 High Similarity NPC239966
0.8812 High Similarity NPC203020
0.8808 High Similarity NPC140502
0.8808 High Similarity NPC157816
0.8805 High Similarity NPC133984
0.8797 High Similarity NPC186316
0.8795 High Similarity NPC473630
0.879 High Similarity NPC157898
0.8774 High Similarity NPC106138
0.8758 High Similarity NPC34587
0.8758 High Similarity NPC100998
0.8758 High Similarity NPC476382
0.8758 High Similarity NPC34927
0.8758 High Similarity NPC71780
0.8758 High Similarity NPC252292
0.875 High Similarity NPC160780
0.875 High Similarity NPC469384
0.875 High Similarity NPC289811
0.8743 High Similarity NPC472380
0.8743 High Similarity NPC472384
0.8743 High Similarity NPC472382
0.8742 High Similarity NPC186406
0.8742 High Similarity NPC228357
0.8735 High Similarity NPC4390
0.872 High Similarity NPC116745
0.8704 High Similarity NPC61594
0.8704 High Similarity NPC56735
0.8704 High Similarity NPC148273
0.8701 High Similarity NPC476865
0.8701 High Similarity NPC199928
0.8693 High Similarity NPC110063
0.8693 High Similarity NPC232228
0.8693 High Similarity NPC160378
0.8688 High Similarity NPC472860
0.8688 High Similarity NPC475663
0.8688 High Similarity NPC1913
0.8688 High Similarity NPC286919
0.8683 High Similarity NPC264735
0.8675 High Similarity NPC153755
0.8675 High Similarity NPC175107
0.8675 High Similarity NPC288452
0.8675 High Similarity NPC179505
0.8675 High Similarity NPC156709
0.8675 High Similarity NPC289690
0.8675 High Similarity NPC190003
0.8671 High Similarity NPC87403
0.8654 High Similarity NPC98809
0.8654 High Similarity NPC476394
0.865 High Similarity NPC147596
0.8645 High Similarity NPC232992
0.8642 High Similarity NPC472859
0.8642 High Similarity NPC25389
0.8642 High Similarity NPC311803
0.8636 High Similarity NPC476868
0.8636 High Similarity NPC476866
0.8636 High Similarity NPC476864
0.8636 High Similarity NPC476869
0.8634 High Similarity NPC231475
0.8634 High Similarity NPC57072
0.8631 High Similarity NPC268533
0.8631 High Similarity NPC472385
0.8631 High Similarity NPC198324
0.8625 High Similarity NPC470896
0.8625 High Similarity NPC473275
0.8614 High Similarity NPC235260
0.8614 High Similarity NPC20505
0.8614 High Similarity NPC206123
0.8614 High Similarity NPC155763
0.8614 High Similarity NPC244776
0.8614 High Similarity NPC212748
0.8614 High Similarity NPC72249
0.8614 High Similarity NPC116864
0.8609 High Similarity NPC100389
0.8608 High Similarity NPC106818
0.8606 High Similarity NPC298847
0.8605 High Similarity NPC475360
0.86 High Similarity NPC37468
0.8599 High Similarity NPC470934
0.8599 High Similarity NPC471214
0.8599 High Similarity NPC188393
0.8599 High Similarity NPC205054
0.8599 High Similarity NPC32197
0.8598 High Similarity NPC88243
0.8598 High Similarity NPC165720
0.859 High Similarity NPC1580
0.859 High Similarity NPC192568
0.859 High Similarity NPC473138
0.859 High Similarity NPC472969
0.859 High Similarity NPC28776
0.859 High Similarity NPC471076
0.8589 High Similarity NPC33298
0.8589 High Similarity NPC22324
0.8589 High Similarity NPC285108
0.8581 High Similarity NPC98356
0.858 High Similarity NPC119125
0.858 High Similarity NPC173837
0.858 High Similarity NPC139571
0.858 High Similarity NPC166277
0.858 High Similarity NPC477895
0.858 High Similarity NPC217520
0.858 High Similarity NPC35167
0.8571 High Similarity NPC49344
0.8571 High Similarity NPC101191
0.8571 High Similarity NPC476867
0.8571 High Similarity NPC292443
0.8571 High Similarity NPC115760
0.8571 High Similarity NPC237435
0.8571 High Similarity NPC477848
0.8571 High Similarity NPC43211
0.8571 High Similarity NPC210094
0.8571 High Similarity NPC135277
0.8563 High Similarity NPC472386
0.8555 High Similarity NPC205721
0.8554 High Similarity NPC270578
0.8554 High Similarity NPC52382
0.8554 High Similarity NPC229687
0.8554 High Similarity NPC138927
0.8554 High Similarity NPC120099
0.8554 High Similarity NPC223747
0.8554 High Similarity NPC225434
0.8554 High Similarity NPC219904
0.8554 High Similarity NPC203050
0.8553 High Similarity NPC202700
0.8553 High Similarity NPC19380
0.8553 High Similarity NPC146277
0.8543 High Similarity NPC67349
0.8543 High Similarity NPC279676
0.8543 High Similarity NPC470413
0.8543 High Similarity NPC126206
0.8543 High Similarity NPC138738
0.8538 High Similarity NPC470445
0.8538 High Similarity NPC36138
0.8538 High Similarity NPC470447
0.8538 High Similarity NPC470449
0.8538 High Similarity NPC470446
0.8537 High Similarity NPC88043
0.8537 High Similarity NPC223006
0.8537 High Similarity NPC134047
0.8537 High Similarity NPC272750
0.8537 High Similarity NPC173729
0.8535 High Similarity NPC306890
0.8535 High Similarity NPC259347
0.8535 High Similarity NPC94871
0.8535 High Similarity NPC476398
0.8535 High Similarity NPC470933
0.8535 High Similarity NPC471062
0.8535 High Similarity NPC476386
0.8535 High Similarity NPC473427
0.8528 High Similarity NPC217950
0.8526 High Similarity NPC229264
0.8521 High Similarity NPC89127
0.8521 High Similarity NPC233994
0.8521 High Similarity NPC471669
0.8521 High Similarity NPC144097
0.8521 High Similarity NPC61904
0.8521 High Similarity NPC211532
0.8519 High Similarity NPC179914

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC469654 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8571 High Similarity NPD4338 Clinical (unspecified phase)
0.8462 Intermediate Similarity NPD7808 Phase 3
0.8402 Intermediate Similarity NPD7251 Discontinued
0.8393 Intermediate Similarity NPD7074 Phase 3
0.8383 Intermediate Similarity NPD3818 Discontinued
0.8366 Intermediate Similarity NPD7266 Discontinued
0.8343 Intermediate Similarity NPD6797 Phase 2
0.8333 Intermediate Similarity NPD7054 Approved
0.8284 Intermediate Similarity NPD7472 Approved
0.8269 Intermediate Similarity NPD6190 Approved
0.8187 Intermediate Similarity NPD7685 Pre-registration
0.8121 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.8121 Intermediate Similarity NPD7075 Discontinued
0.8118 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.811 Intermediate Similarity NPD3817 Phase 2
0.8103 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.8079 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.8075 Intermediate Similarity NPD1653 Approved
0.8061 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.8059 Intermediate Similarity NPD7228 Approved
0.805 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.8047 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.8047 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.8047 Intermediate Similarity NPD6166 Phase 2
0.7988 Intermediate Similarity NPD1934 Approved
0.7988 Intermediate Similarity NPD37 Approved
0.7977 Intermediate Similarity NPD6559 Discontinued
0.7964 Intermediate Similarity NPD6234 Discontinued
0.7953 Intermediate Similarity NPD3751 Discontinued
0.7952 Intermediate Similarity NPD4967 Phase 2
0.7952 Intermediate Similarity NPD4966 Approved
0.7952 Intermediate Similarity NPD4965 Approved
0.7952 Intermediate Similarity NPD3882 Suspended
0.7939 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.7892 Intermediate Similarity NPD5402 Approved
0.7886 Intermediate Similarity NPD8312 Approved
0.7886 Intermediate Similarity NPD8313 Approved
0.7882 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7831 Intermediate Similarity NPD8455 Phase 2
0.7831 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.7816 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7792 Intermediate Similarity NPD6233 Phase 2
0.7771 Intermediate Similarity NPD6801 Discontinued
0.7765 Intermediate Similarity NPD7199 Phase 2
0.775 Intermediate Similarity NPD4628 Phase 3
0.7727 Intermediate Similarity NPD6798 Discontinued
0.7725 Intermediate Similarity NPD2801 Approved
0.7719 Intermediate Similarity NPD3787 Discontinued
0.7692 Intermediate Similarity NPD6355 Discontinued
0.7683 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7683 Intermediate Similarity NPD5403 Approved
0.767 Intermediate Similarity NPD7240 Approved
0.7667 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7662 Intermediate Similarity NPD7095 Approved
0.7647 Intermediate Similarity NPD7435 Discontinued
0.7616 Intermediate Similarity NPD6232 Discontinued
0.7607 Intermediate Similarity NPD6799 Approved
0.76 Intermediate Similarity NPD5844 Phase 1
0.7595 Intermediate Similarity NPD7097 Phase 1
0.7586 Intermediate Similarity NPD7473 Discontinued
0.758 Intermediate Similarity NPD1933 Approved
0.7561 Intermediate Similarity NPD5401 Approved
0.7558 Intermediate Similarity NPD8127 Discontinued
0.7556 Intermediate Similarity NPD8434 Phase 2
0.7548 Intermediate Similarity NPD3027 Phase 3
0.7545 Intermediate Similarity NPD4380 Phase 2
0.7516 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7516 Intermediate Similarity NPD1613 Approved
0.7515 Intermediate Similarity NPD1512 Approved
0.7515 Intermediate Similarity NPD7819 Suspended
0.7515 Intermediate Similarity NPD1465 Phase 2
0.7469 Intermediate Similarity NPD6674 Discontinued
0.7468 Intermediate Similarity NPD447 Suspended
0.7452 Intermediate Similarity NPD4062 Phase 3
0.744 Intermediate Similarity NPD6599 Discontinued
0.7438 Intermediate Similarity NPD7033 Discontinued
0.7409 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.7409 Intermediate Similarity NPD7874 Approved
0.7405 Intermediate Similarity NPD7966 Clinical (unspecified phase)
0.7405 Intermediate Similarity NPD4060 Phase 1
0.7399 Intermediate Similarity NPD5494 Approved
0.7394 Intermediate Similarity NPD6777 Approved
0.7394 Intermediate Similarity NPD6776 Approved
0.7394 Intermediate Similarity NPD6779 Approved
0.7394 Intermediate Similarity NPD6780 Approved
0.7394 Intermediate Similarity NPD1511 Approved
0.7394 Intermediate Similarity NPD6781 Approved
0.7394 Intermediate Similarity NPD6778 Approved
0.7394 Intermediate Similarity NPD6782 Approved
0.7391 Intermediate Similarity NPD2935 Discontinued
0.7386 Intermediate Similarity NPD4379 Clinical (unspecified phase)
0.7349 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.7317 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7317 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7317 Intermediate Similarity NPD4110 Phase 3
0.7317 Intermediate Similarity NPD4109 Clinical (unspecified phase)
0.7301 Intermediate Similarity NPD1549 Phase 2
0.7294 Intermediate Similarity NPD7411 Suspended
0.7278 Intermediate Similarity NPD3226 Approved
0.7278 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7277 Intermediate Similarity NPD7697 Approved
0.7277 Intermediate Similarity NPD7696 Phase 3
0.7277 Intermediate Similarity NPD7698 Approved
0.7261 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7256 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7255 Intermediate Similarity NPD1091 Approved
0.725 Intermediate Similarity NPD230 Phase 1
0.725 Intermediate Similarity NPD4340 Discontinued
0.7249 Intermediate Similarity NPD7237 Clinical (unspecified phase)
0.7241 Intermediate Similarity NPD919 Approved
0.724 Intermediate Similarity NPD8320 Phase 1
0.724 Intermediate Similarity NPD7870 Phase 2
0.724 Intermediate Similarity NPD7871 Phase 2
0.724 Intermediate Similarity NPD8319 Approved
0.7239 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.7239 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.7225 Intermediate Similarity NPD7768 Phase 2
0.7216 Intermediate Similarity NPD7701 Phase 2
0.7204 Intermediate Similarity NPD7296 Approved
0.7197 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7195 Intermediate Similarity NPD4534 Discontinued
0.7194 Intermediate Similarity NPD7783 Phase 2
0.7194 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.7193 Intermediate Similarity NPD6386 Approved
0.7193 Intermediate Similarity NPD6385 Approved
0.7188 Intermediate Similarity NPD7680 Approved
0.7182 Intermediate Similarity NPD7038 Approved
0.7182 Intermediate Similarity NPD7039 Approved
0.7179 Intermediate Similarity NPD8151 Discontinued
0.7175 Intermediate Similarity NPD3926 Phase 2
0.7174 Intermediate Similarity NPD8150 Discontinued
0.7168 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.7158 Intermediate Similarity NPD7090 Clinical (unspecified phase)
0.7152 Intermediate Similarity NPD6832 Phase 2
0.7143 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7135 Intermediate Similarity NPD6823 Phase 2
0.7134 Intermediate Similarity NPD5763 Approved
0.7134 Intermediate Similarity NPD2346 Discontinued
0.7134 Intermediate Similarity NPD5762 Approved
0.7128 Intermediate Similarity NPD6535 Approved
0.7128 Intermediate Similarity NPD6534 Approved
0.7126 Intermediate Similarity NPD5058 Phase 3
0.7117 Intermediate Similarity NPD2799 Discontinued
0.7108 Intermediate Similarity NPD8166 Discontinued
0.7108 Intermediate Similarity NPD3750 Approved
0.7107 Intermediate Similarity NPD7801 Approved
0.7105 Intermediate Similarity NPD7700 Phase 2
0.7105 Intermediate Similarity NPD7699 Phase 2
0.7099 Intermediate Similarity NPD6653 Approved
0.7097 Intermediate Similarity NPD1608 Approved
0.7093 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.7091 Intermediate Similarity NPD5958 Discontinued
0.7089 Intermediate Similarity NPD9494 Approved
0.7076 Intermediate Similarity NPD7458 Discontinued
0.7073 Intermediate Similarity NPD1551 Phase 2
0.7073 Intermediate Similarity NPD2796 Approved
0.707 Intermediate Similarity NPD2797 Approved
0.7066 Intermediate Similarity NPD2354 Approved
0.7066 Intermediate Similarity NPD3887 Approved
0.7063 Intermediate Similarity NPD3764 Approved
0.7063 Intermediate Similarity NPD2313 Discontinued
0.7062 Intermediate Similarity NPD1247 Approved
0.7044 Intermediate Similarity NPD8155 Clinical (unspecified phase)
0.7041 Intermediate Similarity NPD3688 Clinical (unspecified phase)
0.7041 Intermediate Similarity NPD3146 Approved
0.7041 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.7039 Intermediate Similarity NPD5536 Phase 2
0.7039 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7035 Intermediate Similarity NPD7028 Phase 2
0.7032 Intermediate Similarity NPD3705 Approved
0.7025 Intermediate Similarity NPD5647 Approved
0.7012 Intermediate Similarity NPD1510 Phase 2
0.7 Intermediate Similarity NPD6273 Approved
0.699 Remote Similarity NPD7584 Approved
0.6989 Remote Similarity NPD3749 Approved
0.6988 Remote Similarity NPD2424 Discontinued
0.6981 Remote Similarity NPD2861 Phase 2
0.6977 Remote Similarity NPD5808 Clinical (unspecified phase)
0.6976 Remote Similarity NPD5619 Clinical (unspecified phase)
0.6971 Remote Similarity NPD5353 Approved
0.697 Remote Similarity NPD6032 Approved
0.6966 Remote Similarity NPD6959 Discontinued
0.6963 Remote Similarity NPD8090 Clinical (unspecified phase)
0.6962 Remote Similarity NPD1203 Approved
0.6957 Remote Similarity NPD3268 Approved
0.6954 Remote Similarity NPD7585 Approved
0.6948 Remote Similarity NPD1357 Approved
0.6946 Remote Similarity NPD1652 Phase 2
0.6933 Remote Similarity NPD5123 Clinical (unspecified phase)
0.6933 Remote Similarity NPD1899 Clinical (unspecified phase)
0.6933 Remote Similarity NPD5124 Phase 1
0.6923 Remote Similarity NPD1535 Discovery
0.6919 Remote Similarity NPD3686 Approved
0.6919 Remote Similarity NPD3687 Approved
0.6914 Remote Similarity NPD7972 Discontinued
0.6909 Remote Similarity NPD4308 Phase 3
0.6904 Remote Similarity NPD7583 Approved
0.6903 Remote Similarity NPD17 Approved
0.6901 Remote Similarity NPD5049 Phase 3
0.6901 Remote Similarity NPD7314 Clinical (unspecified phase)

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data